Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Parkinson's Disease

Free Subscription 17.06.2024 1 J Neural Transm (Vienna) 2 Mov Disord 1 Nature 2 Neurobiol Dis 2 Neurology 1 Neurosci Lett 1 Neuroscience 3 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

J Neural Transm (Vienna)

1. MOCHIZUKI H
   Pathological mechanisms and treatment of sporadic Parkinson's disease: past, present, and future.
   J Neural Transm (Vienna). 2024 Jun 12. doi: 10.1007/s00702-024-02788.
   PubMed         Abstract available
   
   

   
   Mov Disord

2. KIMURA Y, Mochizuki H
   Targeting Glucagon-Like Peptide 1 Signaling: A Potential Disease Modifying Therapy for Parkinson's Disease.
   Mov Disord. 2024 Jun 14. doi: 10.1002/mds.29884.
   PubMed        
   
   
3. BREFEL-COURBON C, Harroch E, Marques A, Devos D, et al
   Oxycodone or Higher Dose of Levodopa for the Treatment of Parkinsonian Central Pain: OXYDOPA Trial.
   Mov Disord. 2024 Jun 8. doi: 10.1002/mds.29878.
   PubMed         Abstract available
   
   

   
   Nature

4. KRAMER K
   Daily briefing: Autism triples risk of Parkinson's-like symptoms.
   Nature. 2024 May 29. doi: 10.1038/d41586-024-01615.
   PubMed        
   
   

   
   Neurobiol Dis

5. BAARBE J, Brown MJN, Saha U, Tran S, et al
   Cortical modulations before lower limb motor blocks are associated with freezing of gait in Parkinson's disease: an EEG source localization study.
   Neurobiol Dis. 2024 Jun 7:106557. doi: 10.1016/j.nbd.2024.106557.
   PubMed         Abstract available
   
   
6. GAN C, Cao X, Sun H, Ye S, et al
   Multimodal neuroimaging fusion unravel structural-functional-neurotransmitter change in Parkinson's disease with impulse control disorders.
   Neurobiol Dis. 2024;198:106560.
   PubMed         Abstract available
   
   

   
   Neurology

7. YOUNG CB, Cholerton B, Smith AM, Shahid-Besanti M, et al
   The Parkinson's Disease Composite of Executive Functioning: A Measure for Detecting Cognitive Decline in Clinical Trials.
   Neurology. 2024;103:e209609.
   PubMed         Abstract available
   
   
8. HILKENS NA, Hammerton G, De Vries NM, Bloem BR, et al
   Guide to Decomposition of Causal Effects Into Mediation, Interaction, and Direct Effects: Case Study on Aerobic Exercise and Parkinson Disease.
   Neurology. 2024;103:e209547.
   PubMed         Abstract available
   
   

   
   Neurosci Lett

9. MARANO M, Altavista MC, Cassetta E, Brusa L, et al
   The influence of sex on non-motor wearing-off in Parkinson's disease: A WORK-PD post-hoc study.
   Neurosci Lett. 2024 Jun 7:137850. doi: 10.1016/j.neulet.2024.137850.
   PubMed         Abstract available
   
   

   
   Neuroscience

10. HUANG M, Yu H, Lyu X, Pu W, et al
    Region-specific cerebral metabolic alterations in Parkinson's disease patients with/without mild cognitive impairment.
    Neuroscience. 2024 Jun 5:S0306-4522(24)00241.
    PubMed         Abstract available
    
    

    
    PLoS One

11. MILDNER S, Hotz I, Kubler F, Rausch L, et al
    Effects of activity-oriented physiotherapy with and without eye movement training on dynamic balance, functional mobility, and eye movements in patients with Parkinson's disease: An assessor-blinded randomised controlled pilot trial.
    PLoS One. 2024;19:e0304788.
    PubMed         Abstract available
    
    
12. HARRIS DM, O'Bryan SJ, Latella C
    Non-invasive brain stimulation as treatment for motor impairment in people with Parkinson's disease: Protocol for an umbrella review.
    PLoS One. 2024;19:e0304717.
    PubMed         Abstract available
    
    
13. AGLEY L, Hartley P, Lafortune L
    Exploring the experiences, priorities and preferences of people living with Parkinson's on exercise and physical activity promotion in the UK.
    PLoS One. 2024;19:e0304223.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Parkinson's Disease is free of charge.